Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

REPL

Replimune Group Inc

May 27 • 04:00PM ET

4.70

+0.10 2.17 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: CCCC CHRS ZNTL ALLO ALEC CLLS ELDN IMRX LENZ GLSI

| Held by: XBI IWM VTI IWN IBB VXF SCHA DFMC VTWO DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.58	Insider Own	7.68%	Shs Outstand	79.63M	Perf Week	0.00%
Market Cap	388.09M	Forward P/E	-	EPS next Y	-1.63	Insider Trans	-1.75%	Shs Float	76.23M	Perf Month	75.37%
Enterprise Value	195.30M	PEG	-	EPS next Q	-0.66	Inst Own	102.43%	Short Float	27.76%	Perf Quarter	-42.68%
Income	-314.85M	P/S	-	EPS this Y	0.28%	Inst Trans	-12.00%	Short Ratio	3.39	Perf Half Y	-48.91%
Sales	0.00M	P/B	1.78	EPS next Y	46.76%	ROA	-67.19%	Short Interest	21.16M	Perf YTD	-51.65%
Book/sh	2.64	P/C	1.44	EPS next 5Y	28.65%	ROE	-90.88%	52W High	13.24 -64.50%	Perf Year	-44.18%
Cash/sh	3.26	P/FCF	-	EPS past 3/5Y	-10.73% -14.85%	ROIC	-111.33%	52W Low	1.50 213.33%	Perf 3Y	-75.89%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.78% 14.89%	Perf 5Y	-87.82%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-13.96%	Oper. Margin	-	ATR (14)	0.58	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.60	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	53.29	Recom	3.50
Dividend Gr. 3/5Y	- -	Current Ratio	5.60	EPS Q/Q	3.16%	SMA20	14.94%	Beta	0.33	Target Price	2.20
Payout	-	Debt/Eq	0.36	Sales Q/Q	-	SMA50	-0.62%	Rel Volume	0.36	Prev Close	4.60
Employees	479	LT Debt/Eq	0.34	Earnings	Feb 03 BMO	SMA200	-30.61%	Avg Volume	6.24M	Price	4.70
IPO	Jul 20, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.89% 0.00%	Trades		Volume	2,216,462	Change	2.17%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)